Form 4: TransDigm Director Kevin Stein Granted Stock Options

TransDigm Group Director Kevin Stein was granted 518 stock options with an exercise price of $1,291.97, exercisable over five years starting September 30, 2026, contingent on performance targets.

Summary

• Kevin Stein, a Director of TransDigm Group INC (TDG), was granted 518 stock options.
• The options have an exercise price of $1,291.97 per share.
• The transaction date for the grant was November 4, 2025.
• These options become exercisable at 20% per year over five years, commencing September 30, 2026.
• Exercisability is subject to the achievement of annual operating performance targets.
• The options expire on November 4, 2035.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The grant of performance-based stock options to a director is a positive development, aligning management incentives with long-term shareholder value creation. It's a routine compensation event but structured to reward performance.

Positives

• The grant of stock options aligns management incentives with shareholder value creation.
• Performance-based vesting ensures that the options become exercisable only upon the achievement of specific annual operating targets.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged, compliant trading strategy.

Future Outlook

The future exercisability of the granted stock options is contingent on the achievement of annual operating performance targets over the next five years, starting September 30, 2026.

Industry Context

This filing reports a routine equity compensation grant to a director, a common practice across industries to align executive and director incentives with shareholder interests. The use of performance-based vesting is a prevalent trend in corporate governance to link compensation directly to company performance.

Comparison to Industry Standards

• The grant of stock options to directors is a common compensation practice in publicly traded companies, including those in the aerospace and defense industry where TransDigm operates.
• Performance-based vesting, as seen with these options, aligns with best practices in corporate governance, ensuring that equity awards are earned through the achievement of specific company goals, a standard adopted by many S&P 500 companies.
• The exercise price of $1,291.97 reflects the market price at the time of grant, which is typical for incentive stock options.

Corporate Governance

Related Party Transactions

• Grant of 518 stock options to Kevin Stein, a Director of TransDigm Group INC, as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential for increased long-term value if performance targets are met, as director incentives are aligned with company success.
• Employees: No direct impact mentioned, but successful achievement of company performance targets could indirectly benefit all employees.

Next Steps

• Kevin Stein will need to achieve annual operating performance targets for the options to become exercisable starting September 30, 2026.
• The options will vest at 20% per year over five years.

Key Dates

Recommendation

This Form 4 reports a standard equity compensation grant to a director, which is a routine event and does not provide new material information that would significantly alter the investment thesis for TransDigm Group. The performance-based vesting is a positive for governance, but the transaction itself is not a catalyst for a change in recommendation.

Keywords

TransDigm Group, TDG, Kevin Stein, Stock Options, Director Compensation, SEC Form 4, Insider Transaction, Equity Grant, Performance-Based Vesting, Rule 10b5-1